reimbursement

News

France 'first EU country to cover obesity drugs'

France's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.

Market Access

Women's health: Predictions for 2026

A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.

Market Access

Unlocking oncology access: What the OECD findings mean for m...

New policies are shaping the market access landscape, such as the introduction of the EU HTA for oncology medicines.

Market Access

Health equity can be a competitive advantage: What pharma le...

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have a chance to lead – aligning innovation with access drivers and g

News

Trump blocks plan for Medicare to cover weight-loss drugs

A proposal by the Biden administration to cover weight-loss medicines for obesity under Medicare has been axed by the White House.

News

Germany will reimburse haemophilia gene therapy Hemgenix

Germany has agreed to reimburse CSL Behring's haemophilia B gene therapy Hemgenix with a 'unique' outcomes-based payment model.

France 'first EU country to cover obesity drugs'

Women's health: Predictions for 2026

Unlocking oncology access: What the OECD findings mean for m...

Health equity can be a competitive advantage: What pharma le...

Trump blocks plan for Medicare to cover weight-loss drugs

Germany will reimburse haemophilia gene therapy Hemgenix

Moderna jab on trial for cancer-causing syndrome

Discover a new era of healthcare panel engagement: Grounded ...

reimbursement

Editor's Picks